Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Filings indexed 1,245 across all filing types
Latest filing 2021-12-30 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (357 characters) and contains only address and listing department information for stock exchanges, with no substantive content or financial data. There is no indication of a report, announcement, or detailed filing. Given the brevity and lack of content, this is likely a regulatory or administrative communication without substantive report content. According to the rules, such short, non-substantive documents fall under Regulatory Filings (RNS).
2021-12-30 English
This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window for insiders and designated persons due to upcoming unaudited financial results for the quarter ended December 31, 2021. It references regulatory compliance with insider trading regulations and mentions that the board meeting for declaration of unaudited financial results will be intimated later. The document does not contain any financial data or results itself, nor does it include a report or detailed financial statements. It is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (2465 characters), and it serves as a regulatory announcement rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and procedural notices.
2021-12-30 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the publication of a newspaper advertisement about the transfer of unclaimed interim dividends and corresponding equity shares to the Investor Education and Protection Fund (IEPF) Authority. It references compliance with SEBI regulations and the Companies Act, 2013, specifically Section 124(6) and related rules. The content is primarily an announcement informing shareholders about the transfer process and urging them to claim dividends before a specified deadline. There are no financial statements, detailed financial analysis, or management discussion present. The document is not a full report but an announcement of a notice published in newspapers and available on the company's website. The length is about 11,290 characters, but the content is clearly an announcement rather than a report. Therefore, according to the MENU VS MEAL rule, this document should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-12-22 English
In accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of newspaper advertisement of notice published in ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the publication of a newspaper advertisement about the transfer of unclaimed interim dividend and corresponding equity shares to the Investor Education and Protection Fund (IEPF) Authority. It references regulatory compliance under SEBI Listing Obligations and the Companies Act, 2013, and details the process and deadlines for shareholders to claim dividends before transfer. The content is primarily an announcement of a notice published in newspapers and available on the company's website, rather than the actual dividend report or financial statements. The document length is about 11,290 characters, but the content is clearly an announcement of a notice to shareholders, not a full report or financial data. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance communication rather than a dividend notice (DIV) or report publication announcement (RPA) because it includes the full text of the notice and detailed instructions rather than just a brief announcement or link to a report.
2021-12-22 English
Updates
Notice of Dividend Amount Classification · 95% confidence The document text is very short (413 characters) and contains a table with financial year, date of declaration of dividend, and dividend amount information. It specifically mentions an interim dividend for the financial year 2014-2015 and details about the transfer to the Investor Education & Protection Fund. This matches the description of a Notice of Dividend Amount, which announces dividend amounts and payment details to shareholders. There is no indication that this is a full financial report or an announcement of a report publication. Therefore, the document is best classified as a Notice of Dividend Amount (DIV).
2021-12-21 English
In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copy of the communication sent to those concerned shareholders, ....
Regulatory Filings Classification · 95% confidence The document is a notice to shareholders regarding the compulsory transfer of unclaimed interim dividend shares to the Investor Education and Protection Fund (IEPF) Authority. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and the Companies Act, 2013, specifically section 124(6) and related IEPF rules. The content is a formal communication informing shareholders about the transfer of shares due to unclaimed dividends and instructions to prevent such transfer. It does not contain financial statements, audit results, or detailed financial data. The document is essentially an official announcement or notice to shareholders about a regulatory action concerning share transfers related to unclaimed dividends. It is not an annual report, audit report, earnings release, or any other financial report type. Given the nature and content, this fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance-related communications that do not fit other specific categories.
2021-12-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.